Parkinson’s Disease Research Tools

Proteos Neuroscience Brain Research
10/15/2020

More than 6 million people worldwide are living with Parkinson’s Disease.  Proteos has proudly partnered with The Michael J. Fox Foundation to provide high-quality protein reagents in support of Parkinson’s disease research. These reagents are made available to researchers for a small fee thanks to the generosity and involvement of the MJFF and can be ordered directly from Proteos through our website.

Proteos Recombinant Protein Products 

Unfortunately, the 14th Annual PD Therapeutics Conference has been canceled.  In lieu of the in-person conference, The Michael J. Fox Foundation has compiled a webinar series that features presentations on hot topics in PD research and development from leaders in the field.

Parkinson’s Disease Therapeutics Webinars

Tags: Alpha-synuclein, Michael J. Fox Foundation

Customize This